Ambryon Biosciences

AAV-ShH10Y445F Serotype

ShH10 variant with Y445F tyrosine mutation for enhanced intracellular trafficking and 2-5 fold improved transduction in liver and muscle.

TropismLiver (enhanced), muscle, CNS

Characteristics

Y445F tyrosine mutation reducing ubiquitination. Enhanced intracellular trafficking. 2-5 fold transduction improvement versus wild-type ShH10. Maintained broad tropism profile. Reduced vector dose requirements.

Applications

Hemophilia B clinical development. Enhanced liver-directed gene therapy. Applications requiring improved transduction efficiency.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Hauck et al. (2020). Generation and characterization of chimeric recombinant AAV vectors. Mol Ther Methods Clin Dev — Hauck 2020 ShH10-Y445F

Identifiers & revision